Treatment should include a medication discussion
SAMHSA identifies methadone, buprenorphine and naltrexone as medicines used to treat opioid use disorder. Their suitability, access and initiation differ. A qualified clinician should explain the options in the context of current use, physical health, other medicines and preferences. Medication treatment should not be dismissed as a failure of recovery.
Ask what happens beyond withdrawal
A programme that offers a short withdrawal stay should also explain the longer treatment plan. Ask about medication access, a prescriber after discharge and the response to renewed use. Do not change prescribed opioid treatment based on a comparison article or an accommodation package.
Overdose prevention belongs in the plan
Naloxone can reverse an opioid overdose. If an overdose is suspected, call emergency services and administer naloxone if available, following the product instructions and emergency dispatcher’s guidance. Stay with the person if safe. Emergency assessment is still needed even if they respond.
Questions to take to your appointment
- Do you offer or coordinate evidence-based medication treatment?
- Who will prescribe after discharge, and is that appointment booked?
- How do you prepare the person and family for overdose prevention?
- How do you coordinate care when travel crosses national borders?
Before international residential treatment
Ask the destination clinician to review medication access and continuity before travel. Request a written handover process with your home prescriber. Do not assume a medicine, formulation or prescribing arrangement is available in every country. A beautiful residence does not resolve a gap in ongoing treatment.
If someone is unresponsive or breathing abnormally, use emergency help now.
Continuity is part of the treatment decision
Our research on treatment retention and mortality explains why transitions deserve careful planning. Before changing services, ask who will prescribe, when the next appointment occurs and how the receiving team confirms the handover. Do not assume that a referral letter means an appointment has been accepted.
Discuss practical barriers early: travel, pharmacy arrangements, identification requirements, accommodation and the ability to attend appointments. Requirements differ by location and service, so obtain current instructions from the team responsible for care.
What to bring to an assessment
Bring the names of prescribed and non-prescribed substances, recent use patterns, previous treatment and any concerns about pain or mental health. Explain if a dose has been missed or the medication supply is uncertain. The clinician needs accurate information to advise safely; do not improvise a replacement or restart schedule.
If family members are involved, decide what information may be shared and what support they can realistically provide. A relative can help organise appointments, but should not be responsible for making medication decisions.
Make the safety plan concrete
- Know the local emergency number and how to describe the location.
- Ask where naloxone is available and how to use the supplied product.
- Keep treatment contacts and written instructions accessible.
- Ask the team what to do after an interruption, return to use or change in health.
Overdose prevention and ongoing treatment address connected needs. A completed detoxification episode does not itself provide a plan for the following weeks. If a residential service is being considered, ask how it supports evidence-based medication and links the person to continuing care at home. The answer should identify people and appointments, not only promise “aftercare”.
Sources & further reading
Published by AddictionResearch with AI-assisted preparation. General education; no independent clinician review is claimed.
Editorial standards Report a correction